UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.394

Sortiert nach

'Off-the-shelf' allogeneic CAR T cells: development and challenges

Nature reviews. Drug discovery, 2020-03, Vol.19 (3), p.185-199

2020

Volltextzugriff (PDF)

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

Leukemia, 2016-03, Vol.30 (3), p.666-673

2016

Volltextzugriff (PDF)

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.42-48

2014

Volltextzugriff (PDF)

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

Leukemia, 2007-07, Vol.21 (7), p.1436-1441

2007

Volltextzugriff (PDF)

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Leukemia, 2015-09, Vol.29 (9), p.1928-1938

2015

Volltextzugriff (PDF)

Aetiology and Management of Extrahepatic Portal Vein Obstruction in Children: King's College Hospital Experience

Journal of pediatric gastroenterology and nutrition, 2008-11, Vol.47 (5), p.630-634

2008

Volltextzugriff (PDF)

A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.62-67

2015

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1391-1401

2021

Volltextzugriff (PDF)

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

Journal of internal medicine, 2019-04, Vol.285 (4), p.407-418

2019

Volltextzugriff (PDF)

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

Leukemia, 2007-09, Vol.21 (9), p.1937-1944

2007

Volltextzugriff (PDF)

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Haematologica (Roma), 2014-06, Vol.99 (6), p.1041

2014

Volltextzugriff (PDF)

Preclinical modeling of myelodysplastic syndromes

Leukemia, 2017-12, Vol.31 (12), p.2702-2708

2017

Volltextzugriff (PDF)

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Leukemia, 2012-04, Vol.26 (4), p.855-858

2012

Volltextzugriff (PDF)

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Volltextzugriff (PDF)

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1107-1112

2017

Volltextzugriff (PDF)

Life coaching following haematopoietic stem cell transplantation: a mixed-method investigation of feasibility and acceptability

European journal of cancer care, 2015-07, Vol.24 (4), p.531-541

2015

Volltextzugriff (PDF)

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1502-1507

2010

Volltextzugriff (PDF)

The clinical and histopathological spectrum of neutrophilic inflammatory disease encountered in the setting of myelodysplastic syndrome

Clinical and experimental dermatology, 2021-07, Vol.46 (5), p.977-979

2021

Volltextzugriff (PDF)

MASS CYTOMETRY REVEALS A DISTINCT IMMUNOPHENOTYPE IN TELOMEROPATHIES

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S9-S10

2023

Volltextzugriff (PDF)

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.209-215

2017

Volltextzugriff (PDF)

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1519-1525

2017

Volltextzugriff (PDF)

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.633-639

2010

Volltextzugriff (PDF)

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.238-242

2013

Volltextzugriff (PDF)

Clinical significance of acquired somatic mutations in aplastic anaemia

International Journal of Hematology, 2016-08, Vol.104 (2), p.159-167

2016

Volltextzugriff (PDF)

1 – 25 von 1.394

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(905)
Mit Volltextzugriff
(1.149)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.393)
Japanisch
(73)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(619)
Life Sciences & Biomedicine
(551)
Humans
(454)
Male
(255)
Female
(234)
Biological And Medical Sciences
(212)
Hematology
(210)
Middle Aged
(209)
Medical Sciences
(200)
Adult
(196)
Aged
(173)
Oncology
(127)
Hematologic And Hematopoietic Diseases
(106)
Biology
(99)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(99)
Life Sciences & Biomedicine - Other Topics
(99)
Adolescent
(62)
Treatment Outcome
(62)
Aged, 80 And Over
(60)
Immunology
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

'Off-the-shelf' allogeneic CAR T cells: development and challenges

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Aetiology and Management of Extrahepatic Portal Vein Obstruction in Children: King's College Hospital Experience

A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Preclinical modeling of myelodysplastic syndromes

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Life coaching following haematopoietic stem cell transplantation: a mixed-method investigation of feasibility and acceptability

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience

The clinical and histopathological spectrum of neutrophilic inflammatory disease encountered in the setting of myelodysplastic syndrome

MASS CYTOMETRY REVEALS A DISTINCT IMMUNOPHENOTYPE IN TELOMEROPATHIES

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Clinical significance of acquired somatic mutations in aplastic anaemia

Suchergebnisse filtern